An HGH fragment analog studied for fat metabolism through lipolysis without growth promotion.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 2 mg vial takes 0.25 mL of water for a clean 8 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 200 mcg draws to |
|---|---|---|---|
| 2 mg | 0.25 mL | 8 mg/mL | 2.5 units |
| 5 mg | 0.5 mL | 10 mg/mL | 2 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 200 mcg. At 8 mg/mL, that draws to 2.5 units on a U-100 insulin syringe.
Mimics the fat-burning region of human growth hormone, stimulating the breakdown of triglycerides and suppressing fat storage. It targets lipolysis independent of insulin pathways.
AOD-9604 is commonly taken in the morning.
Add 0.25 mL of bacteriostatic water to a 2 mg AOD-9604 vial for a 8 mg/mL solution.
A common AOD-9604 starting dose is 200 mcg, which at 8 mg/mL draws to 2.5 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the AOD-9604 vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.